Connection lost
Server error
In Re Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel and Peter G. Milner Case Brief
Why Top Law Students (And Those Aspiring to Be) Use LSD+ Briefs
Let's be real, law school is a marathon. Our exclusive Flash-to-Full case system is designed by Harvard Law School and MIT grads to match your pace: Quick summaries when you're slammed, detailed analysis when you need to go deep. Only LSD+ offers this kind of flexibility to genuinely fit your study flow.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: The court reversed the PTO’s obviousness rejection of claims for specific DNA sequences, holding that knowledge of a partial protein sequence and general cloning methods does not render the specific DNA encoding that protein obvious due to genetic code redundancy.
Legal Significance: Established that a specific DNA sequence is not obvious merely because the encoded protein (or part of it) and general cloning methods are known, absent prior art suggesting the particular DNA structure.
In Re Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel and Peter G. Milner Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
Deuel claimed isolated and purified DNA and cDNA molecules encoding heparin-binding growth factors (HBGFs). Claims 5 and 7 were for specific cDNA sequences for human and bovine HBGFs, respectively, while Claims 4 and 6 generically covered all DNA sequences encoding these proteins. The U.S. Patent and Trademark Office (PTO) rejected these claims as obvious under 35 U.S.C. § 103. The rejection combined prior art: Bohlen, which disclosed a partial N-terminal amino acid sequence of similar proteins (HBBMs), and Maniatis, which described a general method for gene cloning. The examiner and the Board of Patent Appeals and Interferences reasoned that Bohlen’s disclosure of the protein sequence would motivate one skilled in the art to isolate the corresponding gene using Maniatis’s general cloning methods, thereby rendering the claimed DNA/cDNA molecules obvious. Deuel had isolated the specific cDNAs after determining a partial amino acid sequence of the target protein and subsequently screening cDNA libraries.
Court Holding & Legal Precedent
Issue: Did the prior art disclosure of a partial protein amino acid sequence and a general method for gene cloning render specific cDNA molecules encoding that protein obvious under 35 U.S.C. § 103?
No. The court reversed the Board’s decision, holding that the claimed specific Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit ame
IRAC Legal Analysis
Complete IRAC Analysis for Higher Grades
IRAC (Issue, Rule, Analysis, Conclusion) is the exact format professors want to see in your exam answers. Our exclusive Flash-to-Full briefs combine holding, analysis, and rule statements formatted to match what A+ students produce in exams. These structured briefs help reinforce the essential legal reasoning patterns expected in law school.
Legal Issue
Did the prior art disclosure of a partial protein amino acid sequence and a general method for gene cloning render specific cDNA molecules encoding that protein obvious under 35 U.S.C. § 103?
Conclusion
This case significantly clarified that knowledge of a protein's amino acid sequence Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
Legal Rule
For a chemical compound to be prima facie obvious, the prior art Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
Legal Analysis
The court reasoned that a prima facie case of obviousness for new Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
Flash-to-Full Case Opinions
Flash Summary
- Knowledge of a protein’s partial amino acid sequence and a general